{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "TWD", "exchange": "TWO", "shortName": "MEDIGEN VACCINE BIOLOGICS CORPO", "longName": "Medigen Vaccine Biologics Corporation", "messageBoardId": "finmb_303819083", "market": "tw_market", "marketState": "POSTPOST", "earningsTimestamp": 1683284340, "earningsTimestampStart": 1692010740, "earningsTimestampEnd": 1692360000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -4.36, "epsForward": 1.11, "epsCurrentYear": -4.47, "priceEpsCurrentYear": -13.087249, "sharesOutstanding": 327840000, "bookValue": 15.34, "fiftyDayAverage": 60.96, "fiftyDayAverageChange": -2.459999, "fiftyDayAverageChangePercent": -0.040354315, "twoHundredDayAverage": 83.655075, "tradeable": false, "cryptoTradeable": false, "exchangeTimezoneName": "Asia/Taipei", "exchangeTimezoneShortName": "CST", "gmtOffSetMilliseconds": 28800000, "esgPopulated": false, "regularMarketChangePercent": -2.5, "regularMarketPrice": 58.5, "regularMarketChange": -1.5, "regularMarketTime": 1684128611, "regularMarketDayHigh": 60.5, "regularMarketDayRange": "58.4 - 60.5", "regularMarketDayLow": 58.4, "regularMarketVolume": 1697595, "regularMarketPreviousClose": 60.0, "bid": 58.5, "ask": 58.6, "bidSize": 0, "askSize": 0, "fullExchangeName": "Taipei Exchange", "financialCurrency": "TWD", "regularMarketOpen": 60.0, "averageDailyVolume3Month": 4081232, "averageDailyVolume10Day": 2232800, "fiftyTwoWeekLowChange": 3.0999985, "fiftyTwoWeekLowChangePercent": 0.05595665, "fiftyTwoWeekRange": "55.4 - 160.50653", "fiftyTwoWeekHighChange": -102.00653, "fiftyTwoWeekHighChangePercent": -0.63552886, "fiftyTwoWeekLow": 55.4, "fiftyTwoWeekHigh": 160.50653, "twoHundredDayAverageChange": -25.155075, "twoHundredDayAverageChangePercent": -0.30069992, "marketCap": 19306520576, "forwardPE": 52.7027, "priceToBook": 3.8135593, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "1.0 - Strong Buy", "firstTradeDateMilliseconds": 1442365200000, "priceHint": 2, "symbol": "6547.TWO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "No. 16, Hu Road", "address2": "7th Floor Lane 120 Section 1", "city": "Taipei", "zip": "114", "country": "Taiwan", "phone": "886 2 7745 0830", "fax": "886 2 2658 8980", "website": "https://www.medigenvac.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. The company is developing enterovirus A71 vaccine, which is in Phase III clinical trial to treat enterovirus infection; influenza vaccine, which has completed Phase III clinical trial to treat influenza; dengue vaccine, which has completed Phase II clinical trial for the treatment of dengue fever; respiratory cell fusion virus (RSV) antibody, which is in Phase I clinical trial for the prevention of RSV infection; and COVID-19 vaccine, which is in Phase III clinical trial to prevent COVID-19- severe special infectious pneumonia. Medigen Vaccine Biologics Corporation was founded in 2012 and is based in Taipei, Taiwan. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Yu-Ping  Yang", "title": "Chief Financial Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Shih-Shen  Lee", "title": "Exec. VP of Operations Bus. Unit", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}